STEP-YA for Sleep Disorders in Cancer Survivors
Trial Summary
What is the purpose of this trial?
The purpose of the study is to learn if a single online education session, with or without individualized coaching sessions, can help improve young adult cancer survivors' (YACS) sleep. The name of the study intervention is Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA).
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot change the use of any medications taken to help with insomnia during the study.
What data supports the effectiveness of the STEP-YA treatment for sleep disorders in young adult cancer survivors?
Is the STEP-YA program safe for young adult cancer survivors?
The STEP-YA program, which is a low-intensity educational intervention delivered online, is based on cognitive behavioral therapy for insomnia (CBTI), a well-established and safe treatment for sleep issues. While specific safety data for STEP-YA is not detailed, CBTI is generally considered safe for improving sleep quality in young adult cancer survivors.12456
How is the STEP-YA treatment different from other treatments for sleep disorders in young adult cancer survivors?
STEP-YA is unique because it is a low-intensity educational program delivered online, specifically designed to address the developmental and circadian challenges of young adult cancer survivors, making it more accessible than traditional cognitive behavioral therapy for insomnia (CBTI), which often faces barriers like provider shortages and geographic limitations.12356
Research Team
Christopher Recklitis, PhD, MPH
Principal Investigator
Dana-Farber Cancer Institute
Eligibility Criteria
This trial is for young adult cancer survivors aged 20-39 who have been cancer-free and off active therapy for at least four months. They must be experiencing significant insomnia, able to read/write in English, and diagnosed with cancer over a year ago. Exclusions include bipolar or seizure disorders, untreated sleep apnea, irregular sleep patterns due to work, recent insomnia treatments, or plans to change medications affecting sleep.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a single online education session and complete baseline measures prior to randomization
Coaching
Participants in the coaching condition receive 2 individualized remote coaching sessions
Follow-up
Participants complete follow-up questionnaires at 4 and 8 weeks post-baseline to assess insomnia severity and mood states
Optional Follow-up
Participants may complete an additional insomnia severity assessment at 16 weeks post-intervention
Treatment Details
Interventions
- STEP-YA with Coaching
- STEP-YA without Coaching
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
National Cancer Institute (NCI)
Collaborator